Guizhou Sanli Pharmaceutical Co.,Ltd (SHA:603439)

China flag China · Delayed Price · Currency is CNY
11.75
+0.02 (0.17%)
Jun 23, 2025, 2:45 PM CST
-9.41%
Market Cap 4.71B
Revenue (ttm) 2.13B
Net Income (ttm) 259.93M
Shares Out 401.93M
EPS (ttm) 0.63
PE Ratio 18.67
Forward PE n/a
Dividend 0.34 (2.90%)
Ex-Dividend Date Jun 26, 2025
Volume 2,097,200
Average Volume 4,045,969
Open 11.69
Previous Close 11.73
Day's Range 11.62 - 11.77
52-Week Range 10.69 - 16.50
Beta 0.65
RSI 37.57
Earnings Date Aug 29, 2025

About SHA:603439

GuiZhou SanLi Pharmaceutical Co.,LTD. engages in the research and development, production, and marketing of pharmaceutical products. It offers pediatric medication, respiratory system medication, cardiovascular drugs, injury by fall medication, rehabilitation medicine, GI medicine, and ophthalmic medicine. The company was founded in 1995 and is based in Anshun, China. [Read more]

Sector Healthcare
Founded 1995
Employees 2,852
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603439
Full Company Profile

Financial Performance

In 2024, SHA:603439's revenue was 2.14 billion, an increase of 31.16% compared to the previous year's 1.63 billion. Earnings were 274.03 million, a decrease of -6.38%.

Financial Statements

News

There is no news available yet.